Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Tur

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Plos One|December 17, 2013
Risk acceptance in multiple sclerosis patients on natalizumab treatmentCarmen Tur, Mar Tintoré, Ángela Vidal-Jordana, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2024
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated diseaseAlessia Bianchi, Rosa Cortese, Ferran Prados, et al.
Nature Reviews. Neurology|July 8, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic processÀlex Rovira, Mike P Wattjes, Mar Tintoré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendationsWallace J Brownlee, Christian Wolf, Hans-Peter Hartung, et al.
Nature Reviews. Neurology|September 16, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patientsMike P Wattjes, Àlex Rovira, David Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2019
Single-subject structural cortical networks in clinically isolated syndromeSara Collorone, Ferran Prados, Marloes Hj Hagens, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2017
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factorGeorgina Arrambide, Alex Rovira, Jaume Sastre-Garriga, et al.
Neurology|January 17, 2025
Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MSRené Carvajal, David Guananga-Álvarez, Carmen Tur, et al.
Neurology|August 28, 2016
Contribution of the symptomatic lesion in establishing MS diagnosis and prognosisMar Tintore, Susana Otero-Romero, Jordi Río, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 22, 2021
Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United KingdomOmar A Abdel-Mannan, Celeste Manchoon, Thomas Rossor, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Plos One|December 17, 2013
Risk acceptance in multiple sclerosis patients on natalizumab treatmentCarmen Tur, Mar Tintoré, Ángela Vidal-Jordana, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2024
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated diseaseAlessia Bianchi, Rosa Cortese, Ferran Prados, et al.
Nature Reviews. Neurology|July 8, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic processÀlex Rovira, Mike P Wattjes, Mar Tintoré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendationsWallace J Brownlee, Christian Wolf, Hans-Peter Hartung, et al.
Nature Reviews. Neurology|September 16, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patientsMike P Wattjes, Àlex Rovira, David Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2019
Single-subject structural cortical networks in clinically isolated syndromeSara Collorone, Ferran Prados, Marloes Hj Hagens, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2017
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factorGeorgina Arrambide, Alex Rovira, Jaume Sastre-Garriga, et al.
Neurology|January 17, 2025
Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MSRené Carvajal, David Guananga-Álvarez, Carmen Tur, et al.
Neurology|August 28, 2016
Contribution of the symptomatic lesion in establishing MS diagnosis and prognosisMar Tintore, Susana Otero-Romero, Jordi Río, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 22, 2021
Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United KingdomOmar A Abdel-Mannan, Celeste Manchoon, Thomas Rossor, et al.
Pageof 15